Great re-entry point ladies and gents for DEPO (sharing the wealth)
<table border="0" cellpadding="2" cellspacing="0" width="100%"> <tbody><tr valign="top"><td><nobr><small class="rn">DEPO</small></nobr></td><td align="right"><nobr><small class="rn">5.57</small></nobr></td><td align="right"><nobr><small class="rn">+0.11</small></nobr></td><td align="right"><nobr><small class="rn">News</small></nobr></td></tr></tbody> </table> View Detailed Quote
<small>Delayed 20 mins
Providers - Disclaimer </small>
Was as high as 6.85 2 weeks ago.
The big rush came when ....
(Nasdaq:DEPO - News) announced today that Carl Pelzel has been promoted to executive vice president and chief operating officer. Mr. Pelzel, a proven biotechnology and pharmaceutical executive, joined Depomed earlier this year with over 28 years of experience in discovery, development and global commercialization of pharmaceutical products. "We are fortunate to have someone of Carl's talent and experience to assist with our transition into a commercial entity," said John W. Fara, Ph.D., chairman, president and chief executive officer of Depomed. "Carl has already assumed leadership of the company's operations to support sales and marketing. He will now work to enhance Depomed's commercial opportunities by rapidly developing products that have high market value. I will continue to build shareholder value through the acquisition and development of new products and technologies that will ensure Depomed is positioned for continued success in the future."
Don't miss out everyone, even you Northern.
Their Pipeline is STRONG with tons of FDA apporvals on the horizon and with already 2 approved by the FDA.
Glumetza will be the biggest thing to hit the diabetes market since insulin was discovered.
Multi-dose delivery in one pill is the way of the future, and they have developed the technology to do it.
This one is headed for high teens in the not so distant future.
Good night all.
<table border="0" cellpadding="2" cellspacing="0" width="100%"> <tbody><tr valign="top"><td><nobr><small class="rn">DEPO</small></nobr></td><td align="right"><nobr><small class="rn">5.57</small></nobr></td><td align="right"><nobr><small class="rn">+0.11</small></nobr></td><td align="right"><nobr><small class="rn">News</small></nobr></td></tr></tbody> </table> View Detailed Quote
<small>Delayed 20 mins
Providers - Disclaimer </small>
Was as high as 6.85 2 weeks ago.
The big rush came when ....
(Nasdaq:DEPO - News) announced today that Carl Pelzel has been promoted to executive vice president and chief operating officer. Mr. Pelzel, a proven biotechnology and pharmaceutical executive, joined Depomed earlier this year with over 28 years of experience in discovery, development and global commercialization of pharmaceutical products. "We are fortunate to have someone of Carl's talent and experience to assist with our transition into a commercial entity," said John W. Fara, Ph.D., chairman, president and chief executive officer of Depomed. "Carl has already assumed leadership of the company's operations to support sales and marketing. He will now work to enhance Depomed's commercial opportunities by rapidly developing products that have high market value. I will continue to build shareholder value through the acquisition and development of new products and technologies that will ensure Depomed is positioned for continued success in the future."
Don't miss out everyone, even you Northern.
Their Pipeline is STRONG with tons of FDA apporvals on the horizon and with already 2 approved by the FDA.
Glumetza will be the biggest thing to hit the diabetes market since insulin was discovered.
Multi-dose delivery in one pill is the way of the future, and they have developed the technology to do it.
This one is headed for high teens in the not so distant future.
Good night all.